Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8XSE

SARS-CoV-2 RBD + IMCAS-123 + IMCAS-72 Fab

8XSE の概要
エントリーDOI10.2210/pdb8xse/pdb
EMDBエントリー38617
分子名称Spike protein S1, IMCAS-123 H chain, IMCAS-123 L chain, ... (6 entities in total)
機能のキーワードsars-cov-2, broadly neutralizing antibodies, virus, viral protein/immune system, viral protein-immune system complex
由来する生物種Severe acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2)
詳細
タンパク質・核酸の鎖数5
化学式量合計118404.88
構造登録者
Tong, Z.,Cui, Y.,Xie, Y.,Tong, J.,Gao, G.F.,Qi, J. (登録日: 2024-01-09, 公開日: 2024-07-17, 最終更新日: 2025-07-23)
主引用文献Tong, Z.,Tong, J.,Lei, W.,Xie, Y.,Cui, Y.,Jia, G.,Li, S.,Zhang, Z.,Cheng, Z.,Xing, X.,Ma, H.,Deng, L.,Zhang, R.,Zhao, X.,Liu, K.,Wang, Q.,Qi, J.,Huang, H.,Song, R.,Su, Z.,Wu, G.,Lou, J.,Gao, G.F.
Deciphering a reliable synergistic bispecific strategy of rescuing antibodies for SARS-CoV-2 escape variants, including BA.2.86, EG.5.1, and JN.1.
Cell Rep, 43:114338-114338, 2024
Cited by
PubMed Abstract: The game between therapeutic monoclonal antibodies (mAbs) and continuously emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has favored the virus, as most therapeutic mAbs have been evaded. Addressing this challenge, we systematically explored a reproducible bispecific antibody (bsAb)-dependent synergistic effect in this study. It could effectively restore the neutralizing activity of the bsAb when any of its single mAbs is escaped by variants. This synergy is primarily attributed to the binding angle of receptor-binding domain (RBD)-5, facilitating inter-spike cross-linking and promoting cryptic epitope exposure that classical antibody cocktails cannot achieve. Furthermore, RBD-5 with RBD-2, RBD-6, and RBD-7, alongside RBD-8, also exhibit significantly enhanced effects. This study not only shifts the paradigm in understanding antibody interactions but paves the way for developing more effective therapeutic antibodies against rapidly mutating SARS-CoV-2, with Dia-19 already showing promise against emerging variants like BA.2.86, EG.5.1, and JN.1.
PubMed: 38850530
DOI: 10.1016/j.celrep.2024.114338
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (2.5 Å)
構造検証レポート
Validation report summary of 8xse
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon